✦ LIBER ✦

P19—Influence of Anti-Agalsidase Antibodies on Clinical Outcomes in the Canadian Fabry Disease Initiative Study

✍ Scribed by M. West; D. Bichet; R. Casey; J. Clarke; S. Sirrs; K. LeMoine; C. Auray-Blais

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical effects of neutralizing anti-ag

✍ West, Michael; Bichet, Daniel; Casey, Robin; Clarke, Joe; Sirrs, Sandra; Aerts, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 77 KB

P18—Agalsidase Alfa and Agalsidase Beta

✍ M. West; D. Bichet; R. Casey; J. Clarke; S. Sirrs; K. LeMoine; C. Auray-Blais 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Agalsidase Alfa and Agalsidase beta Have

✍ Michael West; Daniel Bichet; Robin Casey; Joe Clarke; Sandra Sirrs; Kaye LeMoine 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Prospective Results of Switching Enzyme

✍ Michael West; Daniel Bichet; Robin Casey; Joe Clarke; Sandra Sirrs; Gordon Flowe 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Benefit of enzyme replacement therapy in

✍ West, Michael; Bichet, Daniel; Casey, Robin; Clarke, Joe; Sirrs, Sandra; LeMoine 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 60 KB

In Reply to ‘The Influence of Age on the

✍ Zhao Cui; Ming-hui Zhao 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 168 KB